161 related articles for article (PubMed ID: 30234468)
1. The Positive Predictive Value of Onconeural Antibody Testing: A Retrospective Review.
Budhram A; Nicolle MW; Yang L
Can J Neurol Sci; 2018 Sep; 45(5):577-579. PubMed ID: 30234468
[TBL] [Abstract][Full Text] [Related]
2. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
[TBL] [Abstract][Full Text] [Related]
3. Which antibody and which cancer in which paraneoplastic syndromes?
Gozzard P; Maddison P
Pract Neurol; 2010 Oct; 10(5):260-70. PubMed ID: 20858627
[TBL] [Abstract][Full Text] [Related]
4. Onconeural antibodies: improved detection and clinical correlations.
Storstein A; Monstad SE; Haugen M; Mazengia K; Veltman D; Lohndal E; Aarseth J; Vedeler C
J Neuroimmunol; 2011 Mar; 232(1-2):166-70. PubMed ID: 21093932
[TBL] [Abstract][Full Text] [Related]
5. Avidity of onconeural antibodies is of clinical relevance.
Totland C; Ying M; Haugen M; Mazengia K; Storstein A; Aarseth J; Martinez A; Vedeler C
Cancer Immunol Immunother; 2013 Aug; 62(8):1393-6. PubMed ID: 23733227
[TBL] [Abstract][Full Text] [Related]
6. Multiplex serology of paraneoplastic antineuronal antibodies.
Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
[TBL] [Abstract][Full Text] [Related]
7. Presence of onconeural antibodies in sarcoidosis patients with parasarcoidosis syndrome.
Lower EE; Sturdivant M; Baughman RP
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(4):254-260. PubMed ID: 32476961
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
9. Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.
Berger B; Hottenrott T; Rauer S; Stich O
BMC Neurol; 2017 Jan; 17(1):5. PubMed ID: 28068933
[TBL] [Abstract][Full Text] [Related]
10. Hu and Yo antibodies have heterogeneous avidity.
Totland C; Aarseth J; Vedeler C
J Neuroimmunol; 2007 Apr; 185(1-2):162-7. PubMed ID: 17336396
[TBL] [Abstract][Full Text] [Related]
11. The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested.
Ruiz-García R; Martínez-Hernández E; Saiz A; Dalmau J; Graus F
Front Immunol; 2020; 11():1482. PubMed ID: 32760403
[TBL] [Abstract][Full Text] [Related]
12. [Immunology in the clinical practice. XVI. Paraneoplastic syndromes of the nervous system: pathogenesis and diagnosis].
Smitt PA; de Leeuw B; Vecht CJ
Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1652-8. PubMed ID: 9763856
[TBL] [Abstract][Full Text] [Related]
13. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
14. 'Jaw clenching' in anti-Ri--antibody-associated paraneoplastic syndrome.
Bekircan-Kurt CE; Temucin Ç; Elibol B; Saka E
Parkinsonism Relat Disord; 2013 Jan; 19(1):132-3. PubMed ID: 22704901
[No Abstract] [Full Text] [Related]
15. Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique.
Knudsen A; Monstad SE; Dørum A; Lønning PE; Salvesen HB; Drivsholm L; Aarseth JH; Vedeler CA
Cancer Immunol Immunother; 2006 Oct; 55(10):1280-4. PubMed ID: 16429314
[TBL] [Abstract][Full Text] [Related]
16. Onconeural versus paraneoplastic antigens?
Eichmüller SB; Bazhin AV
Curr Med Chem; 2007; 14(23):2489-94. PubMed ID: 17979702
[TBL] [Abstract][Full Text] [Related]
17. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic syndromes.
Dalmau JO; Posner JB
Arch Neurol; 1999 Apr; 56(4):405-8. PubMed ID: 10199327
[TBL] [Abstract][Full Text] [Related]
20. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
Honnorat J
Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
